CS211380B2 - Method of making the 4a-aryl-octyhydro-1h-2-pyrindines - Google Patents

Method of making the 4a-aryl-octyhydro-1h-2-pyrindines Download PDF

Info

Publication number
CS211380B2
CS211380B2 CS777150A CS715077A CS211380B2 CS 211380 B2 CS211380 B2 CS 211380B2 CS 777150 A CS777150 A CS 777150A CS 715077 A CS715077 A CS 715077A CS 211380 B2 CS211380 B2 CS 211380B2
Authority
CS
Czechoslovakia
Prior art keywords
octahydro
pyrindine
formula
hydroxyphenyl
methoxyphenyl
Prior art date
Application number
CS777150A
Other languages
Czech (cs)
English (en)
Inventor
Dennis M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CS804469A priority Critical patent/CS211381B2/cs
Publication of CS211380B2 publication Critical patent/CS211380B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CS777150A 1976-11-02 1977-11-02 Method of making the 4a-aryl-octyhydro-1h-2-pyrindines CS211380B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS804469A CS211381B2 (cs) 1976-11-02 1980-06-24 Způsob výroby cis-4a-aryl oktahydro-lH-2-pyrindinů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
CS211380B2 true CS211380B2 (en) 1982-02-26

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
CS777150A CS211380B2 (en) 1976-11-02 1977-11-02 Method of making the 4a-aryl-octyhydro-1h-2-pyrindines

Country Status (26)

Country Link
JP (1) JPS5356669A (ru)
AR (1) AR223454A1 (ru)
AT (1) ATA782177A (ru)
AU (1) AU513679B2 (ru)
BE (1) BE860314A (ru)
CA (1) CA1100136A (ru)
CS (1) CS211380B2 (ru)
DD (1) DD133795A5 (ru)
DE (1) DE2748466A1 (ru)
DK (1) DK485277A (ru)
ES (3) ES463784A1 (ru)
FR (1) FR2369267A1 (ru)
GB (1) GB1590155A (ru)
GR (1) GR70053B (ru)
HU (1) HU176231B (ru)
IE (1) IE45901B1 (ru)
IL (1) IL53236A0 (ru)
NL (1) NL7712053A (ru)
NZ (1) NZ185539A (ru)
PH (1) PH12590A (ru)
PL (3) PL108610B1 (ru)
PT (1) PT67194B (ru)
RO (3) RO72900A (ru)
SE (3) SE7712218L (ru)
SU (3) SU812174A3 (ru)
ZA (1) ZA776497B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL117572B1 (en) * 1977-12-27 1981-08-31 Lilly Co Eli Process for preparing novel derivatives of trans-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindine3,4,4a,5,6,7,7a-oktagidro-1h-2-piridina
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
EP2670752B1 (en) 2011-02-02 2016-03-16 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
EP2675812B1 (en) 2011-02-18 2017-08-30 Vertex Pharmaceuticals Incorporated Chroman - spirocyclic piperidine amides as modulators of ion channels
CN103517910B (zh) 2011-03-14 2016-12-14 沃泰克斯药物股份有限公司 作为离子通道调节剂的吗啉-螺环哌啶酰胺

Also Published As

Publication number Publication date
NZ185539A (en) 1979-12-11
SE8103106L (sv) 1981-05-18
SE7712218L (sv) 1978-05-02
PT67194A (en) 1977-11-01
AR223454A1 (es) 1981-08-31
PL108610B1 (en) 1980-04-30
PL108466B1 (en) 1980-04-30
CA1100136A (en) 1981-04-28
SU812174A3 (ru) 1981-03-07
AU513679B2 (en) 1980-12-18
IE45901B1 (en) 1982-12-29
ES463783A1 (es) 1979-07-16
FR2369267A1 (fr) 1978-05-26
ATA782177A (de) 1981-10-15
RO77935A (ro) 1981-12-25
FR2369267B1 (ru) 1980-05-16
IE45901L (en) 1978-05-02
AU3023577A (en) 1979-05-10
PH12590A (en) 1979-06-27
PL201885A1 (pl) 1978-12-04
JPS5356669A (en) 1978-05-23
ES472276A1 (es) 1979-10-01
SU845777A3 (ru) 1981-07-07
GR70053B (ru) 1982-07-26
PL109690B1 (en) 1980-06-30
PT67194B (en) 1979-03-23
GB1590155A (en) 1981-05-28
RO72900A (ro) 1981-11-04
SE8103107L (sv) 1981-05-18
BE860314A (fr) 1978-04-28
DK485277A (da) 1978-05-03
RO78300A (ro) 1982-04-12
NL7712053A (nl) 1978-05-05
DE2748466A1 (de) 1978-05-03
ES463784A1 (es) 1978-06-16
ZA776497B (en) 1979-06-27
SU913941A3 (en) 1982-03-15
HU176231B (en) 1981-01-28
IL53236A0 (en) 1977-12-30
DD133795A5 (de) 1979-01-24

Similar Documents

Publication Publication Date Title
RU2102387C1 (ru) Производные n-ацил-2,3-бензодиазепина, или их стереоизомеры, или кислые соли присоединения, обладающие биологической активностью, связанной с воздействием на центральную нервную систему, и фармакологически активная композиция на их основе
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
JPWO2002074746A1 (ja) ベンゾアゼピン誘導体
US8501762B2 (en) Tetrahydroprotoberberine compounds, the synthetic method and the use thereof
HU211928A9 (en) Therapeutically useful 2-aminotetraline derivatives
CS211380B2 (en) Method of making the 4a-aryl-octyhydro-1h-2-pyrindines
JP2656594B2 (ja) ジアミン化合物、その製法及び該化合物を含有する高血圧症及び炎症を治療するための医薬
CS214696B2 (en) Method of making the 9-aminoalcylfluorenes
US5025009A (en) Novel benzazepine derivatives
JPS63258869A (ja) 三環式アミン、その製法及び医薬組成物
Cannon et al. Congeners of the. alpha. conformer of dopamine derived from octahydrobenz [h] isoquinoline
JP2016516814A (ja) コンブレタスタチン類似体
CS203940B2 (en) Process for preparing aryloktahydropyridines
HU205908B (en) Process for producing 9-amino-1,4-alkano-1,2,3,4-tetrahydro-acridine and compounds of analogue structure and pharmaceutical compositions containing them as active component
US6610725B1 (en) Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
CS211381B2 (cs) Způsob výroby cis-4a-aryl oktahydro-lH-2-pyrindinů
HU193711B (en) Process for preparing benzazepine derivatives
US4276296A (en) Substituted benzopyrano[3,4-c]pyridines, compositions and use thereof
US4141893A (en) Decahydrocyclopent[c]azepines
US5508401A (en) Substituted dibenzo[a,d]cycloheptene NMDA antagonists
US4278797A (en) Intermediates to phenylmorphans and method of preparation thereof
US5137908A (en) 4-azahexacyclododecane compounds
BG60436B2 (bg) 1-окса-2-оксо-8-азаспиро(4,5)декани,фармацевтични състави, които ги съдържат,и метод за получаването им
KR840000033B1 (ko) 이소퀴놀린 유도체의 제조방법
KR810000583B1 (ko) 4a-아릴-옥타하이드로-1H-2-피린딘류의 제조방법